Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000343416

Medchemexpress LLC ONO-2952 | 895169-20-7 | 99.5% | 398.86 | 10 MG
SDP

Catalog No. 5000343416
Encompass_Preferred

ONO-2952 is a potent, selective, and orally active translocator protein 18 kDa (TSPO) antagonist. It is more selective for TSPO than other receptors, transporters, ion channels, and enzymes. It exerts anti-stress effects by inhibiting excessive activation of the noradrenergic system in the brain without causing amnesic effects. This product has potential for irritable bowel syndrome treatment and is for research use only.

  • Potent, selective, and orally active translocator protein 18 kDa (TSPO) antagonist with Ki of 0.33-9.30 nM for rat and human TSPO.
  • More selective for TSPO than other receptors, transporters, ion channels, and enzymes.
  • Exerts anti-stress effects through inhibition of excessive activation of the noradrenergic system in the brain without the amnesic effect.
  • Potential for irritable bowel syndrome treatment.

Catalog No. 50-003-43416 Supplier Medchemexpress LLC Supplier No. HY11119110MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

ONO-2952 is a potent, selective, and orally active translocator protein 18 kDa (TSPO) antagonist. It is more selective for TSPO than other receptors, transporters, ion channels, and enzymes. It exerts anti-stress effects by inhibiting excessive activation of the noradrenergic system in the brain without causing amnesic effects. This product has potential for irritable bowel syndrome treatment and is for research use only.

  • Potent, selective, and orally active translocator protein 18 kDa (TSPO) antagonist with Ki of 0.33-9.30 nM for rat and human TSPO.
  • More selective for TSPO than other receptors, transporters, ion channels, and enzymes.
  • Exerts anti-stress effects through inhibition of excessive activation of the noradrenergic system in the brain without the amnesic effect.
  • Potential for irritable bowel syndrome treatment.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.